Discussion Forums > Working Towards a Cure
Bluebird Bio Releases Data on Current Gene Therapy Trials
Sharmin:
Hello Canadian_Family,
I hope that you are feeling better.
As for the SMKCC trials, I feel like SK has swallowed the vector and all of Errant Gene's rights to it. I don't know if they will ever follow through with the trials because their results were not as remarkable (marketable) as bluebird bio's initial results. Likely because of the low intensity conditioning.
I am still a fan of Sadelain's vector and hope that trials will continue.
Andy Battaglia:
FYI, I should have a call with bluebird late in May. I don't know if they'll give me any new info or if it's just so the new rep can introduce herself.
Sharmin:
That's great Andy, I look forward to hearing what they have to say. Hopefully the e-beta thals continue to do well - I'm sure they are ambitiously pursuing a superior vector that can treat beta zero.
Canadian_Family:
Thanks Sharmin. I recovered and doing fine.
SMKCC methodology and idea was very appealing to beta thal 0 (low intensity regimen). It would be a shame if SMKCC will not follow through with the trials. I know that estimated study completion date is July 2016. I will keep my fingers crossed till that date.
Andy,
Thanks for maintaining the relationship with Bluebird. Hope you continue to get information from them.
catchR:
Latest article on gene therapy: Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
Authors: Jorge Mansilla-Soto,1 Isabelle Riviere,1 Farid Boulad,1,2 and Michel Sadelain1,*
Also attached is the full text PDF of the article.
warm regards,
R
Navigation
[0] Message Index
[#] Next page
[*] Previous page
Go to full version